# Anticonvulsant Potential of the Essential Oil of Croton Heliotropiifolius Kunth: In Vivo and In Silico Approach

**Authors:** Maria Elane S. da Cunha, Angélica L. Soares, Esdras M. S. Lima, Francisco A. S. Filho, Ricardo M. Ramos, Rosemarie B. Marques, Francisco Das C. P. de Andrade, Anderson N. Mendes, Evandro Paulo S. Martins

PMC · DOI: 10.1021/acsomega.5c04107 · ACS Omega · 2026-02-04

## TL;DR

This study explores the anticonvulsant effects of an essential oil from Croton heliotropiifolius, showing it may help treat epilepsy by interacting with key brain receptors.

## Contribution

The study combines in vivo and in silico methods to identify anticonvulsant compounds in Croton heliotropiifolius essential oil.

## Key findings

- OCH essential oil increased seizure latency and survival in animals at 200 mg/kg.
- Sesquiterpenes in OCH showed strong binding to GABAA and NMDA receptors.
- Molecular dynamics simulations confirmed stability of key compound-receptor complexes.

## Abstract

Epilepsy is a chronic condition that significantly impacts
the
quality of life of many individuals, underscoring the urgent need
for the identification of safe and effective anticonvulsant agents.
In this context, medicinal plants have emerged as a promising source
of bioactive compounds for treating epilepsy. This study involved
an in vivo and in silico investigation of the anticonvulsant activity
of the essential oil from the leaves of Croton heliotropiifolius Kunth (OCH). In vivo experiments revealed that the essential oil
promoted a significant increase in seizure latency and survival rate
in animals treated with OCH at a dose of 200 mg/kg, indicating an
anticonvulsant effect. To understand the possible receptors and sites
of action of the compounds in the oil, we performed a molecular docking
study with GABAA and NMDA receptors. Additionally, we calculated
the electronic properties of the phytoconstituents at the B3LYP/6–311++G­(d,p)/SMD
level. The results of the molecular docking studies revealed that
the sesquiterpenes α-bulnesene, δ-cadinene, and β-bourbonene,
which are present in OCH, have a high affinity for the GABAA receptor, with binding energies ranging from −10.0 to −9.1
kcal/mol. These compounds primarily interact with the receptors through
hydrophobic forces, highlighting the importance of interaction with
Phe77 of the γ2–(E) subunit of GABAA. Docking analysis of NMDA revealed a higher affinity for the sesquiterpene
guaiadiene, with a binding energy of −8.0 kcal/mol. Molecular
dynamics simulations indicate that the α-bulnesene–GABAA and guaiadiene–NMDA complexes remained stable over
100 ns. DFT analysis revealed that the most promising ligands are
more stable and have moderate to strong electrophilicity. This research
provides valuable insights for the identification of new molecules
in the development of herbal medicines for the treatment of epilepsy,
suggesting that the anticonvulsant effect of OCH may be related to
the modulation of the GABAA receptor or NMDA.

## Linked entities

- **Proteins:** Gabrg1 (gamma-aminobutyric acid type A receptor subunit gamma 1), Nmdar1 (NMDA receptor 1)
- **Chemicals:** α-bulnesene (PubChem CID 520826), δ-cadinene (PubChem CID 441005), β-bourbonene (PubChem CID 62566)
- **Diseases:** epilepsy (MONDO:0005027)
- **Species:** Croton heliotropiifolius (taxon 316785)

## Full-text entities

- **Genes:** GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) [NCBI Gene 2904] {aka DEE27, EIEE27, GluN2B, MRD6, NMDAR2B, NR2B}, Gabrg1 (gamma-aminobutyric acid type A receptor subunit gamma 1) [NCBI Gene 14405] {aka GabaA, GabaA/BZ}, GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) [NCBI Gene 2902] {aka DEE101, GluN1, MRD8, NDHMSD, NDHMSR, NMD-R1}, SOCS1 (suppressor of cytokine signaling 1) [NCBI Gene 8651] {aka AISIMD, CIS1, CISH1, JAB, SOCS-1, SSI-1}, IGKV2D-30 (immunoglobulin kappa variable 2D-30) [NCBI Gene 28881] {aka A1, IGKV2D30}, IGKV5-2 (immunoglobulin kappa variable 5-2) [NCBI Gene 28907] {aka B2, IGKV52}, ABAT (4-aminobutyrate aminotransferase) [NCBI Gene 18] {aka GABA-AT, GABAT, NPD009}, WARS1 (tryptophanyl-tRNA synthetase 1) [NCBI Gene 7453] {aka GAMMA-2, HMN9, HMND9, IFI53, IFP53, NEDMSBA}
- **Diseases:** death (MESH:D003643), brain damage (MESH:D001925), Epilepsy (MESH:D004827), Toxicity (MESH:D064420), glutamate toxicity (MESH:C537425), cortical developmental malformations (MESH:D054220), neuronal death (MESH:D009410), depression (MESH:D003866), neurodegeneration (MESH:D019636), inflammatory (MESH:D007249), insomnia (MESH:D007319), fatigue (MESH:D005221), SMA (MESH:D013226), neurological disorder (MESH:D009461), convulsions (MESH:D012640)
- **Chemicals:** PTZ (MESH:D010433), BDZ (MESH:D001569), Na+ (MESH:D012964), Pilocarpine (MESH:D010862), OCH (-), Ifenprodil (MESH:C010739), valproate sodium (MESH:D014635), Cl- (MESH:D002713), Phe (MESH:D010649), sabinene (MESH:C035127), Oil (MESH:D009821), Monoterpenes (MESH:D039821), phenytoin (MESH:D010672), carbamazepine (MESH:D002220), Sesquiterpenes (MESH:D012717), beta-elemene (MESH:C445979), hydrogen (MESH:D006859), acid (MESH:D000143), oxygen (MESH:D010100), methylscopolamine (MESH:D019832), Met (MESH:D008715), -PBSA (MESH:C437084), alpha-phellandrene (MESH:C005403), 1,8-cineol (MESH:D000077591), limonene (MESH:D000077222), C (MESH:D002244), alpha-terpineol (MESH:C016775), clonazepam (MESH:D002998), myrcene (MESH:C509595), delta-cadinene (MESH:C000607799), beta-Bourbonene (MESH:C542377), DZP (MESH:D003975), EOs (MESH:D009822), terpenes (MESH:D013729), alpha-terpinene (MESH:C018669), Water (MESH:D014867), Tyr (MESH:D014443), alpha-pinene (MESH:C005451), Val (MESH:D014633), beta-pinene (MESH:C010789), alpha-Bulnesene (MESH:C512113), isoborneol (MESH:C022871), GABA (MESH:D005680), beta-phellandrene (MESH:C058582), NMDA (MESH:D016202)
- **Species:** Homo sapiens (human, species) [taxon 9606], Croton heliotropiifolius (species) [taxon 316785], Croton (genus) [taxon 100370], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917805/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917805/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917805/full.md

---
Source: https://tomesphere.com/paper/PMC12917805